TransEnterix (TRXC) Misses Q3 EPS by 1c

Go back to TransEnterix (TRXC) Misses Q3 EPS by 1c

TransEnterix (TRXC) Announces Repayment of Hercules Term Loan and Provides Update on AutoLap Transaction

November 8, 2019 4:26 PM EST

TransEnterix, Inc. (NYSE: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the repayment of all amounts owed under the loan agreement with Hercules Capital, Inc. (Hercules) (NYSE: HTGC) and provided an update on the AutoLap transaction.

... More

TransEnterix (TRXC) Appoints Anthony Fernando as President and CEO

November 8, 2019 4:20 PM EST

TransEnterix, Inc. (NYSE: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that the Companys Board of Directors has appointed Anthony Fernando, the Companys current Chief Operating Officer and Chief Technology Officer, as President and Chief Executive Officer and a member of the Board of Directors, effective November 8, 2019. Mr. Fernando succeeds Todd Pope who is stepping down from his positions as President and Chief Executive Officer. Mr. Pope is committed to assisting with the transition and will serve as a... More